Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02876055 · ClinicalTrials.gov registry record · Phase 4
Analgesic Efficacy of Interscalene Nerve Block Versus Local Infiltration Analgesia Following Total Shoulder Arthroplasty
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 125
- Enrollment target
NCT02876055: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02876055 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02876055, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 125 participants
- Enrollment target
Study Summary
Total shoulder arthroplasty (TSA) is considered to be a major surgical procedure resulting in severe postoperative pain, especially in the first 48 hours after surgery. The use of interscalene brachial plexus nerve block remains the cornerstone for analgesia following shoulder surgery; however, with the advent of local infiltration analgesia (LIA), there has been increasing interest in its use for total joint arthroplasty. Since the benefits of local infiltration analgesia within a comprehensive multi-modal analgesia clinical pathway have yet to be established for total shoulder arthroplasty, the Investigators plan to assess and compare analgesia outcomes between three intervention groups: single shot interscalene brachial plexus block (SISB), continuous interscalene brachial plexus block (CISB), and local infiltration analgesia (LIA).
Interventions
- DRUG Single shot interscalene nerve block
- DRUG Continuous interscalene nerve block
- DRUG Local Infiltration Analgesia (LIA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02876055
The ClinicalTrials.gov registry entry for NCT02876055 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Single shot interscalene nerve block is the first listed.
NCT02876055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02876055 about?
NCT02876055 is a clinical study titled "Analgesic Efficacy of Interscalene Nerve Block Versus Local Infiltration Analgesia Following Total Shoulder Arthroplasty". Total shoulder arthroplasty (TSA) is considered to be a major surgical procedure resulting in severe postoperative pain, especially in the first 48 hours after surgery. The use of interscalene brachial plexus nerve block remains the cornerstone for analgesia following shoulder surgery; however, with...
What is the current status of trial NCT02876055?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 125 participants. The study started on 2016-11. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02876055?
The interventions under investigation include: Single shot interscalene nerve block (DRUG), Continuous interscalene nerve block (DRUG), Local Infiltration Analgesia (LIA) (DRUG).
Who is sponsoring clinical trial NCT02876055?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.